|LETTER TO EDITOR
|Year : 2021 | Volume
| Issue : 1 | Page : 49
Expected RATE of vaccine-associated paralytic poliomyelitis: A simulation analysis regarding transition from the trivalent to bivalent oral poliovirus vaccine
Sora Yasri1, Viroj Wiwanitkit2
1 Private Academic Practice, Dr. DY Patil University, Pune, Maharashtra, India
2 Honorary Professor, Dr. DY Patil University, Pune, Maharashtra, India
|Date of Submission||07-Aug-2019|
|Date of Acceptance||26-Jun-2020|
|Date of Web Publication||27-May-2021|
Private Academic Practice
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Yasri S, Wiwanitkit V. Expected RATE of vaccine-associated paralytic poliomyelitis: A simulation analysis regarding transition from the trivalent to bivalent oral poliovirus vaccine. Int J Prev Med 2021;12:49
|How to cite this URL:|
Yasri S, Wiwanitkit V. Expected RATE of vaccine-associated paralytic poliomyelitis: A simulation analysis regarding transition from the trivalent to bivalent oral poliovirus vaccine. Int J Prev Med [serial online] 2021 [cited 2021 Oct 17];12:49. Available from: https://www.ijpvmjournal.net/text.asp?2021/12/1/49/316996
Poliomyelitis is a preventable infection by vaccine. At present, natural disease exists in some countries, especially those in Africa. The vaccine-associated paralytic poliomyelitis (VAPP) is an unwanted adverse event of vaccination. Recently, transition from the trivalent to bivalent oral poliovirus vaccine becomes a global public health manipulation. Thailand is a tropical country in Indochina that already implemented the transition (in April 2016). Of interest, the study on overall poliovirus shredding rate in random collected stool in Thailand showed similar observed rates prior and post transition (estimated 0.44%).
Here, the authors performed a mathematical model study to find the expected VAPP rate in Thailand. The primary included data for further analysis included: (a) frequencies of isolated vaccine-related poliovirus and (b) the reported rate of VAPP in Thailand before transition of vaccine [Table 1]. First, the frequencies of isolated vaccine-related polio virus strains were determined based on the available data. The mentioned primary data are used for construction of mathematical model based on path probability calculation. The path probability is the chance that an event will occur if the event occurs in that path. In the present model, a path is a polio virus strain (PV1, PV2, or PV3). The final rate is calculated using the following formula “VAPP rate due to a polio virus strain = frequency of that strain × rate of VAPP before transition.”
|Table 1: Derive data according to mathematical modeling in the present study|
Click here to view
For pre-transition, the expected VAPP rates due to PV1, PV2, and PV3 are equal to less than 0.00001650%, 0.00001650%, and 0.00000825%, respectively. For post-transition, the expected rates of VAPP due to PV1, PV2, and PV3 are less than 0.00000165%, 0%, and 0.00000165%, respectively. The overall expected VAPP rate is equal to less than 0.00000330%. There is no change of mathematical model derived overall VAPP but there is a change of the strain specific rate. Now, the surveillance for VAPP according to PV1 and PV2 is still necessary.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
World Health Organization. Polio vaccines: WHO position paper, March 2016-recommendations. Vaccine 2017;35:1197-9.
Bahl S, Hasman A, Eltayeb AO, James Noble D, Thapa A. The switch from trivalent to bivalent oral poliovirus vaccine in the South-East Asia region. J Infect Dis 2017;216(Suppl_1):S94-S100.
Chansaenroj J, Chuchaona W, Thanusuwannasak T, Duang-In A, Puenpa J, Vutithanachot V, et al
. Prevalence of poliovirus vaccine strains in randomized stool samples from 2010 to 2018: Encompassing transition from the trivalent to bivalent oral poliovirus vaccine. Virusdisease 2019;30:201-6.
Kumthip K, Khamrin P, Maneekarn N. Detection of poliovirus infection in children with acute gastroenteritis in Chiang Mai, Thailand. J Med Virol 2017;89:775-81.
Kijphati R, Pongsuwanna Y, Tungcharoensilp S, Onvimol N, Singchai P, Suwanpanyalert P. Situation of vaccine-associated paralytic poliomyelitis case in Thailand, 2001 -2002. Bull Dep Med Sci 2004;46:25-35.